News

TechMARK movers: Sinclair Pharma ends bid talks

30 September 2008 14:36:00

Shares in Sinclair Pharma were sharply lower after the specialty pharmaceutical firm called off bid talks with a third party after deciding an outline proposal regarding a possible offer was unacceptable.

News of an approach was confirmed early last month, although talks in recent weeks have come to nothing.

But the company said it is still in discussions with another party regarding a "strategic opportunity".

Retinal testing specialist Optos was lower even though it said it expects full year revenue to rise by between 16%-17% to $100.5-$101.5m.

"Tightened economic conditions lowered discretionary consumer spending and lengthened sales cycles which impacted on our top line growth in the latter part of the fourth quarter, but overall the business performed well over the course of the full year," said chief executive Thomas W. Butts.

"We have delivered double digit growth in sales and installations in our existing markets, successfully entered into new markets and launched two new retinal imaging platforms," he added.

FTSE TechMARK - Fallers
Sinclair Pharma (SPH) 43.75p -15.05%
Optos (OPTS) 99.00p -13.91%
Emblaze (BLZ) 27.00p -10.74%
Alizyme (AZM) 15.00p -10.45%
AEA Technology (AAT) 35.50p -10.13%
Innovation Group (TIG) 5.19p -9.74%
Oxford Biomedica (OXB) 7.46p -9.02%
Gresham Computing (GHT) 66.00p -8.97%
Vernalis (VER) 3.35p -8.97%
Redstone (RED) 42.00p -7.69%

FTSE TechMARK - Risers
SDL International (SDL) 339.75p +4.86%
Anite Group (AIE) 32.75p +4.80%
Ricardo Group (RCDO) 324.75p +3.42%
Wolfson Microelectronics (WLF) 102.25p +3.28%
Elan Corporation (ELA) € 7.13 +2.74%
Fidessa (FDSA) 725.00p +2.69%
Vislink (VLK) 30.00p +2.56%
Alphameric (ALM) 20.00p +2.56%
Intec Telecom (ITL) 44.00p +2.33%
Vectura Group (VEC) 44.50p +0.56%

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.